https://www.astellas.com/jp/ja/form/technology-healthcare-2019
※Japanese only, no English translation
Background
As announced in its Corporate Strategic Plan 2018 based on its vision “On the forefront of healthcare change to turn innovative science into value for patients”, Astellas is committed to “Developing Rx+TM (1) programs,” which aims to create new healthcare solutions (Rx+TM) that combine expertise and experience cultivated through the prescription drug (Rx) business with attractive seeds from different fields.
As a part of such efforts, in this fiscal year we are implementing the accelerator programs in "Tech ARINA (2)" to match the technologies of the Tokyo Institute of Technology (Tokyo Tech) with our medical knowledge and experience. We will hold this symposium to let everyone know about our latest efforts for the challenge to evolution which may be realized by connecting healthcare and technology. Also, we would like to talk about the healthcare in the future with the visitors.
Click here for the Technology×Healthcare 2018 held last year. ※Japanese only, no English translation
(1) Rx+TM creates new patient values on every “Patient Journey” that combines our expertise and experiences with technology and knowledge from different fields to build new revenue streams separate from our core Rx products
(2) Tech ARINA: It stands for Tokyo Tech-Astellas Rx+ INnovation Award. Idea contest for healthcare research themes using science and technology related to Astellas' wish list is held, and joint research on accelerator programs will be conducted between Tokyo Tech and Astellas for social implementation of selected ideas.
Overview
| Name of the Event: | Technology×Healthcare 2019 -The Challenge to Evolution: Connection between Healthcare and Technology- |
| Date: | December 23rd, 2019 14:00-19:30 (start accepting: 13: 30) |
| Venue: |
Kuramae Hall on the 1st floor of Tokyo Tech Front |
| Target participants: | People who are interested in the collaboration of technology and healthcare (students are welcome) |
| Capacity: | 300 people (If the number of applicants exceeds the limit, we will draw lots.) |
| Participation fees: | Free of charge (prior application is needed) |
| Sponsorship: | Co-sponsored by Tokyo Institute of Technology / Innovations and Future Creation Inc. (MIRAI SOUZOU) / Astellas Pharma Inc. |
※Japanese only, no English translation
| Time | Contents | Speaker | Title |
| 14:00 - 14:10 | Opening Remarks 1 | Astellas Pharma Inc. Representative Director, President and CEO Kenji Yasukawa, Ph.D. |
Developing Rx+TM Programs ~ Creation of new healthcare solution ~ |
| 14:10 - 14:20 | Opening Remarks 2 | Tokyo Institute of Technology President Kazuya Masu |
Advanced Technology & Challenges by Tokyo Tech |
| 14:20 ‐ 15:25 | Session1 | Chairperson Astellas Pharma Inc. Senior Vice President, Rx+ Business Accelerator Yuta Watanabe |
Activities of Astellas' Rx+ Business Accelerator |
| 14:25 - 14:45 | Astellas Pharma Inc. Rx+ Business Accelerator Kohsuke Shakushiro |
Rx+ StoryTM ~ A world realized by Rx+TM ~ |
|
| 14:45 - 15:05 | Astellas Pharma Inc. Rx+ Business Accelerator Motohiro Kanayama |
Exercise×Science | |
| 15:05 - 15:25 | Moff Inc. President Akinori Takahagi |
Rehabilitation and exercise support using wearable and motion capture technology |
|
| 15:25 - 15:35 | Bio Break | ||
| 15:35 - 16:40 | session2 | Chairperson Innovations and Future Creation Inc. (MIRAI SOUZOU) CEO Hiroyuki Okada |
Forefront of Overseas Health Tech Start-ups |
| 15:40 - 16:00 | Astellas Pharma Inc. Rx+ Business Accelerator Sumiho Nakatsu |
A Look into HealthTech Scene in Silicon Valle | |
| 16:00 - 16:20 | Aniwo Ltd. Head of Japan, Executive Officer Business Development Eiji Matsuyama |
The Israel Healthcare startups~the boom is coming~ | |
| 16:20 - 16:40 | Deloitte Tohmatsu Consulting LLC Partner Takeshi Yanagimoto |
Evolving Digital Health in China : How we can leverage this trend? | |
| 16:40 - 16:50 | Bio Break | ||
| 16:50 - 18:20 | Session3 | Chairperson Astellas Pharma Inc. Rx+ Business Accelerator Tatsuhisa Takahashi |
Tech ARINA, The project to search for engineering seeds that matches healthcare |
| 17:00-17:20 | Tokyo Institute of Technology Fujie Group, School of Life Science and Technology Hajime Fujita |
Body-conformable and battery-free, wireless wearable device | |
| 17:20-17:40 | Tokyo Institute of Technology Department of Mechanical Engineering, School of Engineering Associate Professor Tohru Yagi |
Research and development on bio-hybrid prosthetic hand using neural regeneration | |
| 17:40-18:00 | Tokyo Institute of Technology Department of Computer Science of Technology Associate Professor Masahiro Takinoue |
Innovative healthcare opened up by molecular robot technology -toward tiny programmable robots that can perform diagnosis and treatment in the body- | |
| 18:00-18:20 | Tokyo Institute of Technology Department of Chemical Science and Engineering, School of Materials and Chemical Technology Associate Professor Keita Yamada |
Non-invasive detection of blood glucose levels based on natural isotopic signature of breath acetone | |
| 18:20 - 18:25 | Closing Remarks 1 | Tokyo Institute of Technology Executive Vice President for Research Osamu Watanabe |
|
| 18:25 - 18:30 | Closing Remarks 2 | Astellas Pharma Inc. Representative Director, Corporate Executive Vice President, Chief Strategy Officer (CStO) and Chief Financial Officer (CFO) Naoki Okamura |
|
| 18:30 - 19:30 | Networking, Reception |
If you are interested in this symposium, please contact to [email protected]
